Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Global Blood Therapeutics, Inc. - Common Stock (NQ:GBT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 68.47 (25)
Ask (Size) 68.49 (90)
Prev. Close 68.49
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 67,463,704
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biotech Stocks Well-Positioned For The Fourth Quarter ↗
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. 
Via Talk Markets
News headline image
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets

Performance

More News

Read More
News headline image
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗
Via Investor's Business Daily
News headline image
Global Blood Therapeutics's Return On Capital Employed Overview ↗
Via Benzinga
News headline image
Where Global Blood Therapeutics Stands With Analysts ↗
Via Benzinga
News headline image
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics ↗
Via Investor's Business Daily
News headline image
Pfizer Scoops Up Sickle Disease Player For $5B ↗
Via Benzinga
News headline image
Global Blood Therapeutics's Return On Capital Employed Overview ↗
Via Benzinga
News headline image
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal ↗
Via Benzinga
News headline image
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗
Via Investor's Business Daily
News headline image
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗
Via Investor's Business Daily
News headline image
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗
Via Investor's Business Daily
News headline image
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US ↗
Via Benzinga
News headline image
8 Analysts Have This to Say About Global Blood Therapeutics ↗
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022 ↗
Via Benzinga
News headline image
Global Blood Therapeutics: Q2 Earnings Insights ↗
Via Benzinga
News headline image
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal ↗
Via Benzinga
News headline image
TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week ↗
Via InvestorPlace
News headline image
GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics ↗
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗
Via Benzinga
News headline image
Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT
From Halper Sadeh LLP
Via Business Wire
News headline image
Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8 ↗
Via Benzinga
News headline image
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗
Via Benzinga

Frequently Asked Questions

Is Global Blood Therapeutics, Inc. - Common Stock publicly traded?
Yes, Global Blood Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Global Blood Therapeutics, Inc. - Common Stock trade on?
Global Blood Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Global Blood Therapeutics, Inc. - Common Stock?
The ticker symbol for Global Blood Therapeutics, Inc. - Common Stock is GBT on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.